December 17, 2019 9:01am

News: Roche (RHHBY) to complete its $4.3 billion takeover of Spark Therapeutics (ONCE) after U.S. and British authorities ruled the deal would not hurt competition in hemophilia A treatment – finally. The Federal Trade Commission (FTC) and Britain's Competition and Markets Authority (CMA) approved the deal without demanding asset sales.

Pre-open indications:  SELL – BMRN, IONS and RENE.L; BUY – on news, PSTI, ONCE and MESO

Don’t get too comfortable; unfortunately share pricing strength is a short-term enemy.  Momentum with increased volume will encroach on share pricing’s upside; if you were a subscriber … you would understand why!

 

We crave explanations because they give us an illusion of control

 

Dow futures are UP +0.08% (-22 points), S&P futures are UP +0.13% (+4 points) and NASDAQ futures are UP +0.17% (+14 points)

 

U.S. stock index futures are strengthening to a positive open lower this Tuesday morning ;

European stocks retreat after record rally; UK’s Johnson revamps “hard” exit in  Brexit threat;

Asia Pacific stocks were up as Mainland Chinese shares led markets; sentiment continues to be buoyed by a recent phase one trade deal reached between Beijing and Washington;

 

Data Docket: housing starts and building permits for November, and a business leaders survey for December will all be released at 8:30 a.m. ET. Industrial production figures for November will be released at 9:15 a.m. ET, and the latest Job Openings and Labor Turnover Survey (JOLTS) is set to follow shortly thereafter.

 

Henry’omics:

Market focus is largely attuned to global trade developments; the “deal” which is not yet signed, is set to be confirmed in the first week of January

Hopefully, there will be a lessening blow to “our” universe’s share price – the “machines” are preparing to upend the rise of share pricing – be ready.

Monday night’s post’s title:  “the oversold’s ground moved upward. The downside trippers (13) were percentage (%) lean and volume weak while the elevated upside’s (25) percentage (%) and volume increased. Shaking the December tree, 5 negative and 6 positive closes … so far.”

  • The NASDAQ closed UP +79.35 points (+0.91%)
  • The IBB closed up +1.04% while the XBI closed up +1.18%;
  • The range of the 25 upside was +0.57% (MDXG) to +13.66% (BLCM) while the 13 downside ranged from -0.08% (BOLD) to -3.94% (SAGE); 
  • 14 out of the 25 upside had higher than the 3 month average volume;
  • 9 out of the 13 downside had higher than the 3 month average volume;

 

Review the content of Q4’s market:

  • December register 5 negative and 6 positive closes … so far
  • November registered 1 holiday, 12 positive and 8 negative close;
  • October registered 10 positive, 1 neutral and 14 negative closes;

 

Companies in my headlights – It’s your decision; I provide an idea and context:

Pre-open indications:SELL – BMRN, IONS and RENE.L; BUY – on news, PSTI, ONCE and MESO

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.